The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Used for absorption control of antiserum binding.
Concentration information loading...
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
Reconstitute with deionized water. A stock solution of 2 mg/ml is recommended for most absorption control applications.
Delta type opioid receptor
Delta type opioid receptor DOR 1
Delta type opioid receptor DOR1
Delta-type opioid receptor
Opioid receptor delta 1
Function: G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.
Tissue specificity: Detected in oocytes (at protein level). Detected in brain cortex, hypothalamus, hippocampus and olfactory bulb. Detected in oocytes.
Similarity: Belongs to the G-protein coupled receptor 1 family.
Ubiquitinated. A basal ubiquitination seems not to be related to degradation. Ubiquitination is increased upon formation of OPRM1:OPRD1 oligomers leading to proteasomal degradation; the ubiquitination is diminished by RTP4.
Multi pass membrane protein
has not yet been referenced specifically in any publications.